+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

High-Throughput Genomic Screening for Preventive Healthcare Market Size, Share & Trends Analysis Report by Test Type, Technology, Application, End-Use, Region, and Growth Forecasts, 2026-2033

  • PDF Icon

    Report

  • 120 Pages
  • April 2026
  • Region: Global
  • Grand View Research
  • ID: 6241106
REQUEST CUSTOMIZATION
Description Jump to:
The global high-throughput genomic screening for preventive healthcare market size was estimated at USD 846.05 million in 2025 and is projected to reach USD 2.16 billion by 2033, growing at a CAGR of 12.6% from 2026 to 2033. The market growth is driven by the transition from reactive treatment to personalized prevention supported by preventive and precision medicine.

Advancements in high-throughput genomic technologies are further accelerating market expansion by enabling faster, scalable, and more accurate genetic analysis. For instance, in 2025, BGI Genomics and the Thalassemia International Federation highlighted that high‑throughput sequencing improved the accuracy of carrier and at-risk couple identification in thalassemia prevention programs. This advancement strengthens the preventive healthcare paradigm by enabling scalable, precise genetic risk assessments, further accelerating the growth of the high-throughput genomic screening market for preventive healthcare.

Rising consumer awareness and demand for genomic insights are primary drivers of the global high-throughput genomic screening market for preventive healthcare. Individuals are increasingly seeking actionable genetic information to anticipate and mitigate health risks, and this demand is directly driving the adoption of genomic screening technologies such as multi-gene panels and next-generation sequencing. which enables comprehensive risk profiling before symptoms arise. For instance, in 2026, a recent study from 23andMe demonstrated the real-world impact of consumer genomic insights on preventive healthcare: 82% of participants had no prior clinical genetic testing and were unaware of their genetic health risks before using a direct-to-consumer test. After sharing results with healthcare providers, 86% received one or more medical recommendations, including earlier screenings, medications, or preventive surgeries, and 88% of these recommendations were followed. Such real-world adoption demonstrates that consumer-driven demand for genomic insights is not only shaping individual health decisions but also accelerating the overall expansion of the preventive genomic screening market.

The shift from reactive treatment to personalized prevention is driving growth of the high-throughput genomic screening market, as it emphasizes early detection and individualized healthcare. Genetic screening enables the identification of monogenic diseases, hereditary cancer risks such as BRCA1/2 and Lynch syndrome, and metabolic conditions before symptoms appear. Proactive testing, particularly between ages 40-50, targets a critical window when chronic diseases or early-stage cancers often begin to develop. Notably, approximately 50 % of high-risk individuals for hereditary cancers lack a clear family history, meaning traditional reactive approaches would miss them. Tests such as BRCA1/2, CHEK2, and Lynch syndrome panels support personalized surveillance strategies, including earlier mammograms, colonoscopies, or prophylactic interventions. Pharmacogenomic screening further enhances prevention by guiding drug selection and dosage. Providing actionable insights before disease onset, this shift toward precision-based care is directly driving demand for high-throughput genomic screening technologies. For instance, in 2025, international healthcare provider Bupa’s My Genomic Health program in the UK and Spain identified high-risk variants in 4 % of participants and polygenic risk markers in 75 %, enabling early preventive care. This initiative demonstrates how the move from reactive treatment to personalized prevention delivers tailored risk insights, drives adoption of genomic screening, and expands the preventive healthcare market.

Global High-throughput Genomic Screening For Preventive Healthcare Market Report Segmentation

This report forecasts revenue growth at global, regional & country levels and provides an analysis on the industry trends in each of the sub-segments from 2021 to 2033. For this study, the analyst has segmented the global high-throughput genomic screening for preventive healthcare market report based on test type, technology, application, end-use, and region:

Type Outlook (Revenue, USD Million, 2021-2033)

  • Carrier Screening
  • Expanded Carrier Screening (ECS)
  • Targeted Carrier Screening
  • Predictive / Presymptomatic Testing
  • Non-Invasive Prenatal Testing (NIPT)
  • Preimplantation Genetic Testing (PGT)
  • Newborn Screening
  • Pharmacogenomic Testing
  • Others

Outlook (Revenue, USD Million, 2021-2033)

  • Next-Generation Sequencing (NGS)
  • Microarray-based analysis
  • PCR (Polymerase Chain Reaction)
  • FISH (Fluorescence in situ hybridization)
  • CRISPR-based screening platforms
  • Others

Outlook (Revenue, USD Million, 2021-2033)

  • Oncology
  • Cardiovascular diseases
  • Reproductive health & fertility
  • Neurodegenerative disorders
  • Rare genetic diseases
  • Metabolic & chronic disease risk profiling
  • Others

End-use Outlook (Revenue, USD Million, 2021-2033)

  • Hospitals & Diagnostic Laboratories
  • Specialized Genomic Labs
  • Direct-to-Consumer (DTC) Companies
  • Research Institutes & Biopharma Companies
  • Genetic Counseling Centers

Regional Outlook (Revenue, USD Million, 2021-2033)

  • North America
  • U.S.
  • Canada
  • Mexico
  • Europe
  • UK
  • Germany
  • France
  • Italy
  • Spain
  • Denmark
  • Sweden
  • Norway
  • Asia Pacific
  • China
  • Japan
  • India
  • Australia
  • Thailand
  • South Korea
  • Latin America
  • Brazil
  • Argentina
  • Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Why should you buy this report?

  • Comprehensive Market Analysis: Gain detailed insights into the market across major regions and segments.
  • Competitive Landscape: Explore the market presence of key players.
  • Future Trends: Discover the pivotal trends and drivers shaping the future of the market.
  • Actionable Recommendations: Utilize insights to uncover new revenue streams and guide strategic business decisions.

This report addresses:

  • Market intelligence to enable effective decision-making
  • Market estimates and forecasts from 2018 to 2030
  • Growth opportunities and trend analyses
  • Segment and regional revenue forecasts for market assessment
  • Competition strategy and market share analysis
  • Product innovation listings for you to stay ahead of the curve

This product will be delivered within 1-3 business days.

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.2. Segment Definitions
1.2.1. Test Type
1.2.2. Technology
1.2.3. Application
1.2.4. End use
1.2.5. Regional scope
1.2.6. Estimates and forecasts timeline
1.3. Research Methodology
1.4. Information Procurement
1.4.1. Purchased Database
1.4.2. Internal Database
1.4.3. Secondary sources
1.4.4. Primary research
1.4.5. Details of primary research
1.5. Information or Data Analysis
1.5.1. Data analysis models
1.6. Market Formulation & Validation
1.7. Model Details
1.7.1. Commodity flow analysis (Model 1)
1.7.2. Approach 1: Commodity flow approach
1.7.3. Volume price analysis (Model 2)
1.7.4. Approach 2: Volume price analysis
1.8. List of Secondary Sources
1.9. List of Primary Sources
1.10. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Type Test Outlook
2.2.2. Technology Outlook
2.2.3. Application Outlook
2.2.4. End Use Outlook
2.2.5. Regional outlook
2.3. Competitive Insights
Chapter 3. High-Throughput Genomic Screening for Preventive Healthcare Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Market Dynamics
3.2.1. Market driver analysis
3.2.2. Market restraint analysis
3.3. High-Throughput Genomic Screening for Preventive Healthcare Market Analysis Tools
3.3.1. Industry Analysis - Porter’s
3.3.2. PESTEL Analysis
Chapter 4. High-Throughput Genomic Screening for Preventive Healthcare Market: Test Type Estimates & Trend Analysis
4.1. Test Type Market Share, 2025 & 2033
4.2. Segment Dashboard
4.3. Global High-Throughput Genomic Screening for Preventive Healthcare Market by Test Type
4.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
4.5. Carrier Screening
4.5.1. Carrier Screening Market, 2021-2033 (USD Million)
4.6. Predictive / Presymptomatic Testing
4.6.1. Predictive / Presymptomatic Testing Market, 2021-2033 (USD Million)
4.7. Non-Invasive Prenatal Testing (NIPT)
4.7.1. Non-Invasive Prenatal Testing (NIPT)Market, 2021-2033 (USD Million)
4.8. Preimplantation Genetic Testing (PGT)
4.8.1. Preimplantation Genetic Testing (PGT) Market, 2021-2033 (USD Million)
4.9. Newborn Screening
4.9.1. Newborn Screening Market, 2021-2033 (USD Million)
4.10. Pharmacogenomic Testing
4.10.1. Pharmacogenomic Testing Market, 2021-2033 (USD Million)
4.11. Others
4.11.1. Others Market, 2021-2033 (USD Million)
Chapter 5. High-Throughput Genomic Screening for Preventive Healthcare Market: Technology Estimates & Trend Analysis
5.1. Technology Market Share, 2025 & 2033
5.2. Segment Dashboard
5.3. Global High-Throughput Genomic Screening for Preventive Healthcare Market by Technology Outlook
5.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
5.5. Next-Generation Sequencing (NGS)
5.5.1. Next-Generation Sequencing (NGS) Market, 2021-2033 (USD Million)
5.6. Microarray-based analysis
5.6.1. Microarray-based analysis Market, 2021-2033 (USD Million)
5.7. PCR (Polymerase Chain Reaction)
5.7.1. PCR (Polymerase Chain Reaction) Market, 2021-2033 (USD Million)
5.8. FISH (Fluorescence in situ hybridization)
5.8.1. FISH (Fluorescence in situ hybridization) Market, 2021-2033 (USD Million)
5.9. CRISPR-based screening platforms
5.9.1. CRISPR-based screening platforms Market, 2021-2033 (USD Million)
5.10. Others
5.10.1. Other Application Market, 2021-2033 (USD Million)
Chapter 6. High-Throughput Genomic Screening for Preventive Healthcare Market: Application Estimates & Trend Analysis
6.1. Technology Market Share, 2025 & 2033
6.2. Segment Dashboard
6.3. Global High-Throughput Genomic Screening for Preventive Healthcare Market by Application Outlook
6.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
6.5. Oncology
6.5.1. Oncology Market, 2021-2033 (USD Million)
6.6. Cardiovascular diseases
6.6.1. Cardiovascular Diseases Market, 2021-2033 (USD Million)
6.7. Reproductive Health & Fertility
6.7.1. Reproductive Health & Fertility Market, 2021-2033 (USD Million)
6.8. Neurodegenerative disorders
6.8.1. Neurodegenerative Disorders Market, 2021-2033 (USD Million)
6.9. Rare Genetic Diseases
6.9.1. Rare Genetic Diseases Market, 2021-2033 (USD Million)
6.10. Metabolic & chronic disease risk profiling
6.10.1. Metabolic & Chronic Disease Risk Profiling Market, 2021-2033 (USD Million)
6.11. Others
6.11.1. Others Market, 2021-2033 (USD Million)
Chapter 7. High-Throughput Genomic Screening for Preventive Healthcare Market: End Use Estimates & Trend Analysis
7.1. End Use Market Share, 2025 & 2033
7.2. Segment Dashboard
7.3. Global High-Throughput Genomic Screening for Preventive Healthcare Market by End Use Outlook
7.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
7.5. Hospitals & Diagnostic Laboratories
7.5.1. Hospitals & Diagnostic Laboratories Market, 2021-2033 (USD Million)
7.6. Specialized Genomic Labs
7.6.1. Specialized Genomic Labs Market, 2021-2033 (USD Million)
7.7. Direct-to-Consumer (DTC) Companies
7.7.1. Direct-to-Consumer (DTC) Companies Market, 2021-2033 (USD Million)
7.8. Research Institutes & Biopharma Companies
7.8.1. Research Institutes & Biopharma Companies Market, 2021-2033 (USD Million)
7.9. Genetic Counseling Centers
7.9.1. Genetic Counseling Centers Market, 2021-2033 (USD Million)
Chapter 8. High-Throughput Genomic Screening for Preventive Healthcare Market: Regional Estimates & Trend Analysis
8.1. Regional Market Share Analysis, 2025 & 2033
8.2. Regional Market Dashboard
8.3. Global Regional Market Snapshot
8.4. Market Size & Forecasts Trend Analysis, 2021 to 2033:
8.5. North America
8.5.1. U.S.
8.5.2. Canada
8.5.3. Mexico
8.6. Europe
8.6.1. UK
8.6.2. Germany
8.6.3. France
8.6.4. Italy
8.6.5. Spain
8.6.6. Norway
8.6.7. Sweden
8.6.8. Denmark
8.7. Asia-Pacific
8.7.1. Japan
8.7.2. China
8.7.3. India
8.7.4. Australia
8.7.5. South Korea
8.7.6. Thailand
8.8. Latin America
8.8.1. Brazil
8.8.2. Argentina
8.9. MEA
8.9.1. South Africa
8.9.2. Saudi Arabia
8.9.3. UAE
8.9.4. Kuwait
Chapter 9. Competitive Landscape
9.1. Recent Developments & Impact Analysis, by Key Market Participants
9.2. Company/Competition Categorization
9.3. Vendor Landscape
9.3.1. List of key distributors and channel partners
9.3.2. Key customers
9.3.3. Key company market share analysis, 2025
9.3.4. Illumina, Inc
9.3.5. Thermo Fisher Scientific Inc
9.3.6. BGI Genomics.
9.3.7. 10x Genomics
9.3.8. Pacific Biosciences
9.3.9. Natera, Inc
9.3.10. Myriad Genetics, Inc
9.3.11. Fulgent Genetics
9.3.12. Exact Sciences Corporation
9.3.13. 23andMe
9.3.14. Color Health, Inc
List of Tables
Table 1 List of Secondary Sources
Table 2 List of Abbreviations
Table 3 Global high-throughput genomic screening for preventive healthcare market, by Test type, 2021-2033 (USD Million)
Table 4 Global high-throughput genomic screening for preventive healthcare market, by Technology, 2021-2033 (USD Million)
Table 5 Global high-throughput genomic screening for preventive healthcare market, by Application, 2021-2033 (USD Million)
Table 6 Global high-throughput genomic screening for preventive healthcare market, by End use, 2021-2033 (USD Million)
Table 7 North America high-throughput genomic screening for preventive healthcare market, by Country, 2021-2033 (USD Million)
Table 8 North America high-throughput genomic screening for preventive healthcare market, by Test type, 2021-2033 (USD Million)
Table 9 North America high-throughput genomic screening for preventive healthcare market, by Technology, 2021-2033 (USD Million)
Table 10 North America high-throughput genomic screening for preventive healthcare market, by Application, 2021-2033 (USD Million)
Table 11 North America high-throughput genomic screening for preventive healthcare market, by End use, 2021-2033 (USD Million)
Table 12 U.S. high-throughput genomic screening for preventive healthcare market, by Test type, 2021-2033 (USD Million)
Table 13 U.S. high-throughput genomic screening for preventive healthcare market, by Technology, 2021-2033 (USD Million)
Table 14 U.S. high-throughput genomic screening for preventive healthcare market, by Application, 2021-2033 (USD Million)
Table 15 U.S. high-throughput genomic screening for preventive healthcare market, by End use, 2021-2033 (USD Million)
Table 16 Canada high-throughput genomic screening for preventive healthcare market, by Test type, 2021-2033 (USD Million)
Table 17 Canada high-throughput genomic screening for preventive healthcare market, by Technology, 2021-2033 (USD Million)
Table 18 Canada high-throughput genomic screening for preventive healthcare market, by Application, 2021-2033 (USD Million)
Table 19 Canada high-throughput genomic screening for preventive healthcare market, by End use, 2021-2033 (USD Million)
Table 20 Mexico high-throughput genomic screening for preventive healthcare market, by Test type, 2021-2033 (USD Million)
Table 21 high-throughput genomic screening for preventive healthcare market, by Technology, 2021-2033 (USD Million)
Table 22 Mexico high-throughput genomic screening for preventive healthcare market, by Application, 2021-2033 (USD Million)
Table 23 Canada high-throughput genomic screening for preventive healthcare market, by End use, 2021-2033 (USD Million)
Table 24 Europe high-throughput genomic screening for preventive healthcare market, by Country, 2021-2033 (USD Million)
Table 25 Europe high-throughput genomic screening for preventive healthcare market, by Test type, 2021-2033 (USD Million)
Table 26 Europe high-throughput genomic screening for preventive healthcare market, by Technology, 2021-2033 (USD Million)
Table 27 Europe high-throughput genomic screening for preventive healthcare market, by Application, 2021-2033 (USD Million)
Table 28 Europe high-throughput genomic screening for preventive healthcare market, by End use, 2021-2033 (USD Million)
Table 29 Germany high-throughput genomic screening for preventive healthcare market, by Test type, 2021-2033 (USD Million)
Table 30 Germany high-throughput genomic screening for preventive healthcare market, by Technology, 2021-2033 (USD Million)
Table 31 Germany high-throughput genomic screening for preventive healthcare market, by Application, 2021-2033 (USD Million)
Table 32 Germany high-throughput genomic screening for preventive healthcare market, by End use, 2021-2033 (USD Million)
Table 33 UK high-throughput genomic screening for preventive healthcare market, by Test type, 2021-2033 (USD Million)
Table 34 U.K high-throughput genomic screening for preventive healthcare market, by Technology, 2021-2033 (USD Million)
Table 35 UK high-throughput genomic screening for preventive healthcare market, by Application, 2021-2033 (USD Million)
Table 36 U.K high-throughput genomic screening for preventive healthcare market, by End use, 2021-2033 (USD Million)
Table 37 France high-throughput genomic screening for preventive healthcare market, by Test type, 2021-2033 (USD Million)
Table 38 France high-throughput genomic screening for preventive healthcare market, by Technology, 2021-2033 (USD Million)
Table 39 France high-throughput genomic screening for preventive healthcare market, by Application, 2021-2033 (USD Million)
Table 40 France high-throughput genomic screening for preventive healthcare market, by End use, 2021-2033 (USD Million)
Table 41 Italy high-throughput genomic screening for preventive healthcare market, by Test type, 2021-2033 (USD Million)
Table 42 Italy high-throughput genomic screening for preventive healthcare market, by Technology, 2021-2033 (USD Million)
Table 43 Italy high-throughput genomic screening for preventive healthcare market, by Application, 2021-2033 (USD Million)
Table 44 Italy high-throughput genomic screening for preventive healthcare market, by End use, 2021-2033 (USD Million)
Table 45 Spain high-throughput genomic screening for preventive healthcare market, by Test type, 2021-2033 (USD Million)
Table 46 Spain high-throughput genomic screening for preventive healthcare market, by Technology, 2021-2033 (USD Million)
Table 47 Spain high-throughput genomic screening for preventive healthcare market, by Application, 2021-2033 (USD Million)
Table 48 Spain high-throughput genomic screening for preventive healthcare market, by End use, 2021-2033 (USD Million)
Table 49 Denmark high-throughput genomic screening for preventive healthcare market, by Test type, 2021-2033 (USD Million)
Table 50 Denmark high-throughput genomic screening for preventive healthcare market, by Technology, 2021-2033 (USD Million)
Table 51 Denmark high-throughput genomic screening for preventive healthcare market, by Application, 2021-2033 (USD Million)
Table 52 Denmark high-throughput genomic screening for preventive healthcare market, by End use, 2021-2033 (USD Million)
Table 53 Sweden high-throughput genomic screening for preventive healthcare market, by Test type, 2021-2033 (USD Million)
Table 54 Sweden high-throughput genomic screening for preventive healthcare market, by Technology, 2021-2033 (USD Million)
Table 55 Sweden high-throughput genomic screening for preventive healthcare market, by Application, 2021-2033 (USD Million)
Table 56 Sweden high-throughput genomic screening for preventive healthcare market, by End use, 2021-2033 (USD Million)
Table 57 Norway high-throughput genomic screening for preventive healthcare market, by Test type, 2021-2033 (USD Million)
Table 58 Norway high-throughput genomic screening for preventive healthcare market, by Technology, 2021-2033 (USD Million)
Table 59 Norway high-throughput genomic screening for preventive healthcare market, by Application, 2021-2033 (USD Million)
Table 60 Norway high-throughput genomic screening for preventive healthcare market, by End use, 2021-2033 (USD Million)
Table 61 Asia-Pacific high-throughput genomic screening for preventive healthcare market, by Country, 2021-2033 (USD Million)
Table 62 Asia-Pacific high-throughput genomic screening for preventive healthcare market, by Test type, 2021-2033 (USD Million)
Table 63 Asia-Pacific high-throughput genomic screening for preventive healthcare market, by Technology, 2021-2033 (USD Million)
Table 64 Asia-Pacific high-throughput genomic screening for preventive healthcare market, by Application, 2021-2033 (USD Million)
Table 65 Asia-Pacific high-throughput genomic screening for preventive healthcare market, by End use, 2021-2033 (USD Million)
Table 66 China high-throughput genomic screening for preventive healthcare market, by Test type, 2021-2033 (USD Million)
Table 67 China high-throughput genomic screening for preventive healthcare market, by Technology, 2021-2033 (USD Million)
Table 68 China high-throughput genomic screening for preventive healthcare market, by Application, 2021-2033 (USD Million)
Table 69 China high-throughput genomic screening for preventive healthcare market, by End use, 2021-2033 (USD Million)
Table 70 Japan high-throughput genomic screening for preventive healthcare market, by Test type, 2021-2033 (USD Million)
Table 71 Japan high-throughput genomic screening for preventive healthcare market, by Technology, 2021-2033 (USD Million)
Table 72 Japan high-throughput genomic screening for preventive healthcare market, by Application, 2021-2033 (USD Million)
Table 73 Japan high-throughput genomic screening for preventive healthcare market, by End use, 2021-2033 (USD Million)
Table 74 India high-throughput genomic screening for preventive healthcare market, by Test type, 2021-2033 (USD Million)
Table 75 India high-throughput genomic screening for preventive healthcare market, by Technology, 2021-2033 (USD Million)
Table 76 India high-throughput genomic screening for preventive healthcare market, by Application, 2021-2033 (USD Million)
Table 77 India high-throughput genomic screening for preventive healthcare market, by End use, 2021-2033 (USD Million)
Table 78 South Korea high-throughput genomic screening for preventive healthcare market, by Test type, 2021-2033 (USD Million)
Table 79 South Korea high-throughput genomic screening for preventive healthcare market, by Technology, 2021-2033 (USD Million)
Table 80 South Korea high-throughput genomic screening for preventive healthcare market, by Application, 2021-2033 (USD Million)
Table 81 South Korea high-throughput genomic screening for preventive healthcare market, by End use, 2021-2033 (USD Million)
Table 82 Australia high-throughput genomic screening for preventive healthcare market, by Test type, 2021-2033 (USD Million)
Table 83 Australia high-throughput genomic screening for preventive healthcare market, by Technology, 2021-2033 (USD Million)
Table 84 Australia high-throughput genomic screening for preventive healthcare market, by Application, 2021-2033 (USD Million)
Table 85 Australia high-throughput genomic screening for preventive healthcare market, by End use, 2021-2033 (USD Million)
Table 86 Thailand high-throughput genomic screening for preventive healthcare market, by Test type, 2021-2033 (USD Million)
Table 87 Thailand high-throughput genomic screening for preventive healthcare market, by Technology, 2021-2033 (USD Million)
Table 88 Thailand high-throughput genomic screening for preventive healthcare market, by Application, 2021-2033 (USD Million)
Table 89 Thailand high-throughput genomic screening for preventive healthcare market, by End use, 2021-2033 (USD Million)
Table 90 Latin America high-throughput genomic screening for preventive healthcare market, by Country, 2021-2033 (USD Million)
Table 91 Latin America high-throughput genomic screening for preventive healthcare market, by Test type, 2021-2033 (USD Million)
Table 92 Latin America high-throughput genomic screening for preventive healthcare market, by Technology, 2021-2033 (USD Million)
Table 93 Latin America high-throughput genomic screening for preventive healthcare market, by Application, 2021-2033 (USD Million)
Table 94 Latin America high-throughput genomic screening for preventive healthcare market, by End use, 2021-2033 (USD Million)
Table 95 Brazil high-throughput genomic screening for preventive healthcare market, by Test type, 2021-2033 (USD Million)
Table 96 Brazil high-throughput genomic screening for preventive healthcare market, by Technology, 2021-2033 (USD Million)
Table 97 Brazil high-throughput genomic screening for preventive healthcare market, by Application, 2021-2033 (USD Million)
Table 98 Brazil high-throughput genomic screening for preventive healthcare market, by End use, 2021-2033 (USD Million)
Table 99 Argentina high-throughput genomic screening for preventive healthcare market, by Test type, 2021-2033 (USD Million)
Table 100 Argentina high-throughput genomic screening for preventive healthcare market, by Technology, 2021-2033 (USD Million)
Table 101 Argentina high-throughput genomic screening for preventive healthcare market, by Application, 2021-2033 (USD Million)
Table 102 Argentina high-throughput genomic screening for preventive healthcare market, by End use, 2021-2033 (USD Million)
Table 103 Middle East & Africa high-throughput genomic screening for preventive healthcare market, by Country, 2021-2033 (USD Million)
Table 104 Middle East & Africa high-throughput genomic screening for preventive healthcare market, by Test type, 2021-2033 (USD Million)
Table 105 Middle East & Africa high-throughput genomic screening for preventive healthcare market, by Technology, 2021-2033 (USD Million)
Table 106 Middle East & Africa high-throughput genomic screening for preventive healthcare market, by Application, 2021-2033 (USD Million)
Table 107 Middle East & Africa high-throughput genomic screening for preventive healthcare market, by End use, 2021-2033 (USD Million)
Table 108 South Africa high-throughput genomic screening for preventive healthcare market, by Test type, 2021-2033 (USD Million)
Table 109 South Africa high-throughput genomic screening for preventive healthcare market, by Technology, 2021-2033 (USD Million)
Table 110 South Africa high-throughput genomic screening for preventive healthcare market, by Application, 2021-2033 (USD Million)
Table 111 South Africa high-throughput genomic screening for preventive healthcare market, by End use, 2021-2033 (USD Million)
Table 112 Saudi Arabia high-throughput genomic screening for preventive healthcare market, by Test type, 2021-2033 (USD Million)
Table 113 Saudi Arabia high-throughput genomic screening for preventive healthcare market, by Technology, 2021-2033 (USD Million)
Table 114 Saudi Arabia high-throughput genomic screening for preventive healthcare market, by Application, 2021-2033 (USD Million)
Table 115 Saudi Arabia high-throughput genomic screening for preventive healthcare market, by End use, 2021-2033 (USD Million)
Table 116 UAE high-throughput genomic screening for preventive healthcare market, by Test type, 2021-2033 (USD Million)
Table 117 UAE high-throughput genomic screening for preventive healthcare market, by Technology, 2021-2033 (USD Million)
Table 118 UAE high-throughput genomic screening for preventive healthcare market, by Application, 2021-2033 (USD Million)
Table 119 UAE high-throughput genomic screening for preventive healthcare market, by End use, 2021-2033 (USD Million)
Table 120 Kuwait high-throughput genomic screening for preventive healthcare market, by Test type, 2021-2033 (USD Million)
Table 121 Kuwait high-throughput genomic screening for preventive healthcare market, by Technology, 2021-2033 (USD Million)
Table 122 Kuwait high-throughput genomic screening for preventive healthcare market, by Application, 2021-2033 (USD Million)
Table 123 Kuwait high-throughput genomic screening for preventive healthcare market, by End use, 2021-2033 (USD Million)
List of Figures
Figure 1 Market research process
Figure 2 Information Procurement
Figure 3 Primary Research Pattern
Figure 4 Market Research Approaches
Figure 5 Value Chain-Based Sizing & Forecasting
Figure 6 Market Formulation & Validation
Figure 7 High-Throughput Genomic Screening for Preventive Healthcare Market Segmentation
Figure 8 Market Snapshot, 2025
Figure 9 Market Trends & Outlook
Figure 10 Market Driver Relevance Analysis (Current & Future Impact)
Figure 11 Market Restraint Relevance Analysis (Current & Future Impact)
Figure 12 Market Challenge Relevance Analysis (Current & Future Impact)
Figure 13 SWOT Analysis, by Factor (Political & Legal, Economic and Technological)
Figure 14 Porter’s Five Forces Analysis
Figure 15 Global high-throughput genomic screening for preventive healthcare market, Sample Movement Analysis
Figure 16 Global High-Throughput Genomic Screening for Preventive Healthcare Market: Test type Movement Analysis
Figure 17 Global High-Throughput Genomic Screening for Preventive Healthcare Market, for Predictive / Presymptomatic Testing, 2021-2033 (USD Million)
Figure 18 Global High-Throughput Genomic Screening for Preventive Healthcare Market, for Non-Invasive Prenatal Testing (NIPT),2021-2033 (USD Million)
Figure 19 Global High-Throughput Genomic Screening for Preventive Healthcare Market, for Preimplantation Genetic Testing (PGT),2021-2033 (USD Million)
Figure 20 Global High-Throughput Genomic Screening for Preventive Healthcare Market, for Newborn Screening, 2021-2033 (USD Million)
Figure 21 Global High-Throughput Genomic Screening for Preventive Healthcare Market, for Pharmacogenomic Testing,2021-2033 (USD Million)
Figure 22 Global High-Throughput Genomic Screening for Preventive Healthcare Market, Technology Movement Analysis
Figure 23 Global High-Throughput Genomic Screening for Preventive Healthcare Market, for Next-Generation Sequencing (NGS),2021-2033 (USD Million)
Figure 24 Global High-Throughput Genomic Screening for Preventive Healthcare Market, for Microarray-based analysis,2021-2033 (USD Million)
Figure 25 Global High-Throughput Genomic Screening for Preventive Healthcare Market, for PCR (Polymerase Chain Reaction),2021-2033 (USD Million)
Figure 26 Global High-Throughput Genomic Screening for Preventive Healthcare Market, for FISH (Fluorescence in situ hybridization),2021-2033 (USD Million)
Figure 27 Global High-Throughput Genomic Screening for Preventive Healthcare Market, for CRISPR-based screening platforms 2021-2033 (USD Million)
Figure 28 Global High-Throughput Genomic Screening for Preventive Healthcare Market, for Others 2021-2033 (USD Million)
Figure 29 Global High-Throughput Genomic Screening for Preventive Healthcare Market, Application Movement Analysis
Figure 30 Global High-Throughput Genomic Screening for Preventive Healthcare Market, for Oncology 2021-2033 (USD Million)
Figure 31 Global High-Throughput Genomic Screening for Preventive Healthcare Market, for cardiovascular diseases 2021-2033 (USD Million)
Figure 32 Global High-Throughput Genomic Screening for Preventive Healthcare Market, for reproductive health & fertility2021 - 2033 (USD Million)
Figure 33 Global High-Throughput Genomic Screening for Preventive Healthcare Market, for neurodegenerative disorders2021 - 2033 (USD Million)
Figure 34 Global High-Throughput Genomic Screening for Preventive Healthcare Market, for rare genetic diseases 2021-2033 (USD Million)
Figure 35 Global High-Throughput Genomic Screening for Preventive Healthcare Market, for Metabolic & chronic disease risk profiling 2021-2033 (USD Million)
Figure 36 Global High-Throughput Genomic Screening for Preventive Healthcare Market, for others2021 - 2033 (USD Million)
Figure 37 Global High-Throughput Genomic Screening for Preventive Healthcare Market, End Use Movement Analysis
Figure 38 Global High-Throughput Genomic Screening for Preventive Healthcare Market, for Hospitals & Diagnostic Laboratories 2021-2033 (USD Million)
Figure 39 Global High-Throughput Genomic Screening for Preventive Healthcare Market, for Specialized Genomic Labs 2021-2033 (USD Million)
Figure 40 Global High-Throughput Genomic Screening for Preventive Healthcare Market, for Direct-to-Consumer (DTC) Companies 2021-2033 (USD Million)
Figure 41 Global High-Throughput Genomic Screening for Preventive Healthcare Market, for Research Institutes & Biopharma Companies 2021-2033 (USD Million)
Figure 42 Global High-Throughput Genomic Screening for Preventive Healthcare Market, for Genetic Counseling Centers 2021-2033 (USD Million)
Figure 43 Regional Marketplace: Key Takeaways
Figure 44 Regional Outlook, 2025 & 2033
Figure 45 Global High-Throughput Genomic Screening for Preventive Healthcare Market, Region Movement Analysis
Figure 46 North America high-throughput genomic screening for preventive healthcare market, 2021-2033 (USD Million)
Figure 47 U.S. high-throughput genomic screening for preventive healthcare market, 2021-2033 (USD Million)
Figure 48 Canada high-throughput genomic screening for preventive healthcare market, 2021-2033 (USD Million)
Figure 49 Mexico high-throughput genomic screening for preventive healthcare market, 2021-2033 (USD Million)
Figure 50 Europe high-throughput genomic screening for preventive healthcare market, 2021-2033 (USD Million)
Figure 51 Germany high-throughput genomic screening for preventive healthcare market, 2021-2033 (USD Million)
Figure 52 UK high-throughput genomic screening for preventive healthcare market, 2021-2033 (USD Million)
Figure 53 France high-throughput genomic screening for preventive healthcare market, 2021-2033 (USD Million)
Figure 54 Italy high-throughput genomic screening for preventive healthcare market, 2021-2033 (USD Million)
Figure 55 Spain high-throughput genomic screening for preventive healthcare market, 2021-2033 (USD Million)
Figure 56 Denmark high-throughput genomic screening for preventive healthcare market, 2021-2033 (USD Million)
Figure 57 Sweden high-throughput genomic screening for preventive healthcare market, 2021-2033 (USD Million)
Figure 58 Norway high-throughput genomic screening for preventive healthcare market, 2021-2033 (USD Million)
Figure 59 Asia-Pacific high-throughput genomic screening for preventive healthcare market, 2021-2033 (USD Million)
Figure 60 Japan high-throughput genomic screening for preventive healthcare market, 2021-2033 (USD Million)
Figure 61 China high-throughput genomic screening for preventive healthcare market, 2021-2033 (USD Million)
Figure 62 India high-throughput genomic screening for preventive healthcare market, 2021-2033 (USD Million)
Figure 63 Australia high-throughput genomic screening for preventive healthcare market, 2021-2033 (USD Million)
Figure 64 South Korea high-throughput genomic screening for preventive healthcare market, 2021-2033 (USD Million)
Figure 65 Thailand high-throughput genomic screening for preventive healthcare market, 2021-2033 (USD Million)
Figure 66 Latin America high-throughput genomic screening for preventive healthcare market, 2021-2033 (USD Million)
Figure 67 Brazil high-throughput genomic screening for preventive healthcare market, 2021-2033 (USD Million)
Figure 68 Argentina high-throughput genomic screening for preventive healthcare market, 2021-2033 (USD Million)
Figure 69 Middle East and Africa high-throughput genomic screening for preventive healthcare market, 2021-2033 (USD Million)
Figure 70 South Africa high-throughput genomic screening for preventive healthcare market, 2021-2033 (USD Million)
Figure 71 Saudi Arabia high-throughput genomic screening for preventive healthcare market, 2021-2033 (USD Million)
Figure 72 UAE high-throughput genomic screening for preventive healthcare market, 2021-2033 (USD Million)
Figure 73 Kuwait high-throughput genomic screening for preventive healthcare market, 2021-2033 (USD Million)

Companies Mentioned

  • Illumina, Inc.
  • Thermo Fisher Scientific Inc.
  • BGI Genomics
  • 10x Genomics
  • Pacific Biosciences
  • Natera, Inc.
  • Myriad Genetics, Inc.
  • Fulgent Genetics
  • Exact Sciences Corporation
  • 23andMe
  • Color Health, Inc

Table Information

Report AttributeDetails
No. of Pages120
PublishedApril 2026
Forecast Period2025 - 2033
Estimated Market Value ( USD ) in 2025 $ 846.05 Million
Forecasted Market Value ( USD ) by 2033 $ 2160 Million
Compound Annual Growth Rate12.6%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Pan-genomic and Multi-gene Panel Testing Market Size, Share & Trends Analysis Report by Test, Application, End-use, and Region with Growth Forecasts, 2025-2033 - Product Image

Pan-genomic and Multi-gene Panel Testing Market Size, Share & Trends Analysis Report by Test, Application, End-use, and Region with Growth Forecasts, 2025-2033

  • Report
  • 150 Pages
  • Global
From
Global Hereditary Genetic Testing Market: Focus on Product, Sample Type, Technology, Genetic Testing Type, Application Area, Region, and Competitive Landscape - Analysis and Forecast, 2024-2033 - Product Image

Global Hereditary Genetic Testing Market: Focus on Product, Sample Type, Technology, Genetic Testing Type, Application Area, Region, and Competitive Landscape - Analysis and Forecast, 2024-2033

  • Report
  • 113 Pages
  • Global
From
Genome Sequencing Market - A Global and Regional Analysis: Focus on Product, Technology, Application, Type, End User, and Region - Analysis and Forecast, 2024-2033 - Product Image

Genome Sequencing Market - A Global and Regional Analysis: Focus on Product, Technology, Application, Type, End User, and Region - Analysis and Forecast, 2024-2033

  • Report
  • 153 Pages
  • Global
From
DNA Sequencing Products Market Report by Product Type, Application, End-User, and Region 2025-2033 - Product Image

DNA Sequencing Products Market Report by Product Type, Application, End-User, and Region 2025-2033

  • Report
  • 148 Pages
  • Global
From
Carrier Screening Market Size, Share & Trends Analysis Report by Medical Conditions (Spinal Muscular Atrophy, Cystic Fibrosis, Tay-Sachs, Gaucher Disease, Sickle Cell Disease), Type, Technology, End Use, and Region with Growth Forecasts, 2026-2033 - Product Image

Carrier Screening Market Size, Share & Trends Analysis Report by Medical Conditions (Spinal Muscular Atrophy, Cystic Fibrosis, Tay-Sachs, Gaucher Disease, Sickle Cell Disease), Type, Technology, End Use, and Region with Growth Forecasts, 2026-2033

  • Report
  • 150 Pages
  • Global
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.